Cardinal Health, a leading global healthcare services and products company, is headquartered in the United States. Founded in 1971, the company has established itself as a key player in the healthcare industry, primarily focusing on pharmaceutical distribution and medical products. With a strong presence across North America and significant operations in Europe and Asia, Cardinal Health serves a diverse range of healthcare providers, including hospitals, pharmacies, and clinics. The company offers a comprehensive portfolio of services, including supply chain management, medication management, and clinical solutions, which are designed to enhance patient care and operational efficiency. Notably, Cardinal Health is recognised for its commitment to innovation and quality, positioning itself as a trusted partner in the healthcare ecosystem. With a robust market position, Cardinal Health continues to achieve significant milestones, reinforcing its reputation as a vital contributor to the healthcare landscape.
How does Cardinal Health's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Cardinal Health's score of 70 is higher than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, Cardinal Health reported total greenhouse gas emissions of approximately 16,015,000 kg CO2e for Scope 1, about 204,723,000 kg CO2e for Scope 2, and a significant 22,437,666,000 kg CO2e for Scope 3 emissions. This represents a comprehensive approach to emissions reporting, covering all three scopes, with Scope 3 emissions primarily driven by purchased goods and services, which accounted for about 20,772,535,000 kg CO2e. Cardinal Health has set ambitious climate commitments, aiming to reduce its absolute Scope 1 and 2 greenhouse gas emissions by 50% by fiscal year 2030, using a fiscal 2019 baseline. This target was publicly announced in September 2021 and is aligned with science-based targets, as confirmed by the Science Based Targets initiative (SBTi). Additionally, the company aims for 75% of its suppliers by spend to have science-based targets by fiscal year 2028. In the previous year, 2023, Cardinal Health's emissions were approximately 163,044,000 kg CO2e for Scope 1, about 220,684,000 kg CO2e for Scope 2, and around 21,363,272,000 kg CO2e for Scope 3. This indicates a slight decrease in Scope 1 emissions compared to 2022, where Scope 1 emissions were about 167,115,000 kg CO2e. Overall, Cardinal Health's commitment to reducing emissions reflects a proactive stance in addressing climate change within the healthcare sector, demonstrating a clear pathway towards sustainability and accountability in its operations.
Access structured emissions data, company-specific emission factors, and source documents
2009 | 2010 | 2016 | 2017 | 2018 | 2019 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|---|---|---|
Scope 1 | 148,856,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Scope 2 | 212,644,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Scope 3 | - | - | - | - | 00,000,000 | - | - | - | 00,000,000,000 | 00,000,000,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Cardinal Health is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.